Stemcode Peptides Review: Novel Nasal Sprays, but Too Many Red Flags

Overview

Stemcode Peptides has an interesting angle: every product they sell is non-injectable. Their entire catalog consists of nasal sprays (21 products) and oral tablets/capsules (3 products). No lyophilized powders, no reconstitution, no syringes. For researchers who want to avoid injection protocols entirely, this is a unique value proposition.

But unique does not mean trustworthy. Stemcode was founded in October 2025 — making it roughly five months old at the time of this review — and the red flags stack up quickly once you look beyond the product format.

Product Catalog

Stemcode offers 24 products, broken down as follows:

• 21 nasal sprays — BPC-157, TB-500, Selank, Semax, GHK-Cu, PT-141, Ipamorelin, and others
• 3 oral tablets/capsules — MK-677, BPC-157 capsules, and one other

Pricing

Pricing ranges from $50 to $365 per product. These are premium prices compared to injectable equivalents. A 5mg vial of BPC-157 in lyophilized powder form costs $20-$35 from most vendors; Stemcode’s nasal spray is $50. You are paying a significant markup for the convenience of a ready-to-use format.

Whether that markup is justified depends on two things: (1) whether the product quality is there, and (2) whether nasal delivery actually works for the compound in question. Both are questionable — more on that below.

The Bioavailability Question

This is the elephant in the room with Stemcode’s entire business model. Nasal bioavailability varies enormously by peptide size and structure.

Small peptides like Selank and Semax (7 and 7 amino acids respectively) have established intranasal delivery precedent — these were originally developed in Russia as nasal spray formulations. The nasal mucosa can absorb small peptides reasonably well.

But larger peptides like BPC-157 (15 amino acids), TB-500 (43 amino acids), and Tesamorelin (44 amino acids) present a different challenge. As peptide chain length increases, nasal absorption decreases significantly. The nasal mucosa has limitations on the molecular weight it can transport efficiently. Most published research on these compounds uses subcutaneous or intraperitoneal injection in animal models, not intranasal administration.

This does not mean nasal delivery is impossible for larger peptides — absorption enhancers, nanoparticle carriers, and other formulation techniques can improve uptake. But Stemcode provides no information about their formulation technology, no bioavailability data, and no references to research supporting nasal delivery for their specific products. You are essentially taking it on faith that a $109 TB-500 nasal spray delivers a meaningful dose.

For a deeper look at individual compounds and their established administration routes, see our compound guides.

Quality and COA Documentation — The Biggest Problem

Stemcode claims “full COA for every batch” and “99.9% average purity” on their website. These are strong claims. Here is the reality:

Only approximately 7 out of 26 products actually have COAs posted. The remaining 19 products display “Coming Soon” where the COA should be.

This is not a minor gap. Claiming “full COA for every batch” while having certificates for barely a quarter of your catalog is misleading. It is the kind of discrepancy that erodes trust quickly, because if the marketing copy does not accurately represent the COA situation, what else is being overstated?

To make matters worse, no third-party testing lab is identified on any of the COAs that do exist. You cannot cross-reference the results with an independent lab. Compare this to vendors like Particle Peptides, which maintains a searchable vault of 66 batch-specific certificates — Stemcode’s documentation is far behind the standard.

Company Legitimacy Concerns

Stemcode’s registered address is 1309 Coffeen Avenue, Sheridan, Wyoming. If that address sounds familiar, it should — it is one of the most well-known virtual office / registered agent addresses in the United States. Thousands of LLCs and corporations use this address (or addresses on the same street) as their registered agent location. It is a legitimate business practice, but it means the address tells you nothing about where Stemcode actually operates, stores product, or ships from.

Combined with the October 2025 founding date, email-only support, and no named team members, the picture that emerges is a very new company with minimal verifiable infrastructure. This does not automatically mean the products are bad — but it does mean there is essentially no track record to evaluate.

Shipping

Shipping is actually one of Stemcode’s stronger points:

• Processing: Same-day dispatch before 2 PM PST
• Delivery: 1-3 business days (US)
• Free shipping: Orders over $100
• Packaging: Standard packaging (nasal sprays are less temperature-sensitive than lyophilized peptides)

The $100 free shipping threshold is reasonable, and the 1-3 day delivery window is competitive. One advantage of the ready-to-use nasal spray format is that it is inherently more stable during shipping than lyophilized peptides that need cold chain management. The liquid spray format is already reconstituted and sealed, reducing the risk of degradation during transit.

Blog and Educational Content

Stemcode has published 5 blog posts between January and March 2026. The articles are practical and educational (covering topics like nasal spray usage, peptide storage, and basic compound overviews) but the volume is thin. Five posts in three months is not enough to establish the site as a credible educational resource.

The content quality is acceptable but unremarkable — no citations, no depth that would indicate genuine scientific expertise behind the writing.

Return Policy

No returns are accepted on peptide products. Stemcode references a “satisfaction guarantee,” but the actual terms of this guarantee are unclear. What does satisfaction mean? What happens if you receive a damaged product? The policy language is vague enough to be essentially meaningless.

This is not unusual in the peptide vendor space — most vendors restrict returns due to contamination concerns — but combined with the COA gaps, it means you have limited recourse if you receive a product that does not meet your expectations.

Who Might Consider Stemcode?

The only scenario where Stemcode makes sense is for researchers who specifically want non-injectable peptide formats and are willing to accept the bioavailability uncertainty and quality documentation gaps. If you need a Selank or Semax nasal spray (compounds with established intranasal use), Stemcode is one of the few US-based options.

For any other use case — particularly for larger peptides like BPC-157, TB-500, or Tesamorelin — the combination of premium pricing, unproven nasal delivery, and missing COAs makes it hard to recommend Stemcode over established vendors selling injectable formats with proper documentation.

Bottom Line

Stemcode Peptides has a genuinely novel product format that addresses a real market need — not everyone wants to deal with reconstitution and injection protocols. But novelty is not enough. The missing COAs, virtual office address, five-month track record, and unanswered bioavailability questions are too many red flags for us to recommend this vendor at this stage. If Stemcode can close the COA gap, publish bioavailability data for their nasal formulations, and build a longer track record, we will revisit this rating. Until then, approach with significant caution.

All products discussed are for research purposes only. Nothing in this review constitutes medical advice or an endorsement of human use.